The Use of Muzolimine in Nephrotic Syndrome: Diuretic Effect and Tubular Functions
Part of the
Developments in Nephrology
book series (DINE, volume 18)
Muzolimine (M) is a potent diuretic drug recently introduced into clinical use, which shows both high cieling and long acting properties (1,2). It has been held effective in hypertension and in oedematous syndromes from cardiac, hepatic and renal aetiology (3,4,5). This study was designed to evaluate the diuretic or any other effect on tubular transport in patients (pts) with oedema from nephrotic syndrome in course of diverse renal diseases.
KeywordsNephrotic Syndrome Fractional Excretion Titratable Acid Tubular Function Tubular Transport
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Berg KJ, Jørstad S, Tromsdal A. Pharmaterapeutica, 1: 319–32, 1976.Google Scholar
Dal Canton A, Russo D, Gallo R, Conte G, Andreucci V. Brit Med J, 282: 595–8, 1981.CrossRefGoogle Scholar
Heinrich F, Loew D, Dycka J. Curr Med Res Opin, 4: 706–11, 1977.CrossRefGoogle Scholar
Brørs O, Fauchald P, Jacobsen S. Curr Med Res Opin, 6:431–36, 1980.PubMedCrossRefGoogle Scholar
Weisscheid E, Russendorf MG, Ritz E. Clin Nephrol, Vol 19, Suppl. No.l:S 50–3, 1983.Google Scholar
© Martinus Nijhoff Publishing, Boston 1987